These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7528489)

  • 41. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form.
    Presta M; Maier JA; Rusnati M; Ragnotti G
    J Cell Physiol; 1989 Jul; 140(1):68-74. PubMed ID: 2500452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical applications of heparin-binding growth factors.
    Lobb RR
    Eur J Clin Invest; 1988 Aug; 18(4):321-36. PubMed ID: 3139419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological studies of RGTA(11), a heparan sulfate mimetic polymer, efficient on muscle regeneration.
    Meddahi A; Brée F; Papy-Garcia D; Gautron J; Barritault D; Caruelle JP
    J Biomed Mater Res; 2002 Dec; 62(4):525-31. PubMed ID: 12221700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro.
    Morere JF; Letourneur D; Planchon P; Avramoglou T; Jozefonvicz J; Israel L; Crepin M
    Anticancer Drugs; 1992 Dec; 3(6):629-34. PubMed ID: 1283827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacological study of cicatrizing agents].
    MARCY R
    Pathol Biol; 1962 Oct; 10():1559-63. PubMed ID: 13932934
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bone formation in the postoperative scar].
    VANEVSKII VL
    Vestn Khir Im I I Grek; 1955 Nov; 76(11):126-9. PubMed ID: 13299598
    [No Abstract]   [Full Text] [Related]  

  • 48. RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats.
    Lafont J; Baroukh B; Berdal A; Colombier ML; Barritault D; Caruelle JP; Saffar JL
    Growth Factors; 1998; 16(1):23-38. PubMed ID: 9777368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positively charged dextran resin inhibits trabecular bone repair in the rabbit tibial physis.
    Cobos JA; Yang J; Zhang R; Krukowski M; Simmons DJ
    J Biomed Mater Res; 1998 Mar; 39(3):458-61. PubMed ID: 9468056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of cranial bone healing with a heparin-like dextran derivative.
    Albo D; Long C; Jhala N; Atkinson B; Granick MS; Wang T; Meddahi A; Barritault D; Solomon MP
    J Craniofac Surg; 1996 Jan; 7(1):19-22. PubMed ID: 9086897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of repair in experimental calvarial bone defects using calcium sulfate and dextran beads.
    Snyders RV; Eppley BL; Krukowski M; Delfino JJ
    J Oral Maxillofac Surg; 1993 May; 51(5):517-24. PubMed ID: 7683051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological, histocytochemical and ultrastructural study on the effects of surface charge on bone formation in the rabbit mandible.
    Hamamoto N; Hamamoto Y; Nakajima T; Ozawa H
    Arch Oral Biol; 1995 Feb; 40(2):97-106. PubMed ID: 7540834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New approaches to tissue regeneration and repair.
    Meddahi A; Blanquaert F; Saffar JL; Colombier ML; Caruelle JP; Josefonvicz J; Barritault D
    Pathol Res Pract; 1994 Oct; 190(9-10):923-8. PubMed ID: 7534914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CMDBS, functional analogue of heparin sulfate as a new class of corneal ulcer healing agents.
    Fredj-Reygrobellet D; Hristova DL; Ettaiche M; Meddahi A; Jozefonwicz J; Barritault D
    Ophthalmic Res; 1994; 26(6):325-31. PubMed ID: 7536320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New concepts in tissue repair: skin as an example.
    Meddahi A; Caruelle JP; Gold L; Rosso Y; Barritault D
    Diabetes Metab; 1996 Jul; 22(4):274-8. PubMed ID: 8767175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FGFs and their receptors, in vitro and in vivo studies: new FGF receptor in the brain, FGF-1 in muscle, and the use of functional analogues of low-affinity heparin-binding growth factor receptors in tissue repair.
    Soulet L; Chevet E; Lemaitre G; Blanquaert F; Meddahi A; Barritault D
    Mol Reprod Dev; 1994 Sep; 39(1):49-54; discussion 54-5. PubMed ID: 7528027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CMDBS, functional analogs of sulfate heparanes, used as osseous cicatrizing agents].
    Blanquaert F; Barritault D; Saffar JL; Josefonvicz J; Caruelle JP
    Ann Endocrinol (Paris); 1994; 55(2):121-3. PubMed ID: 7528489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparan-like molecules induce the repair of skull defects.
    Blanquaert F; Saffar JL; Colombier ML; Carpentier G; Barritault D; Caruelle JP
    Bone; 1995 Dec; 17(6):499-506. PubMed ID: 8835301
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.